Share Price and Basic Stock Data
Last Updated: January 16, 2026, 3:26 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Sanginita Chemicals Ltd operates within the organic chemicals sector, with its shares priced at ₹11.3 and a market capitalization of ₹29.2 Cr. The company reported a notable fluctuation in sales over recent quarters, with a peak of ₹61.34 Cr in September 2024, followed by a decline to ₹29.16 Cr in December 2023. The trailing twelve months (TTM) sales stood at ₹201 Cr, slightly down from ₹230 Cr reported for the fiscal year ending in March 2025. This indicates a challenging revenue environment, as sales have not shown consistent upward momentum. Comparatively, the reported sales figures suggest volatility, which is characteristic in the chemicals industry, where demand can be influenced by various factors including market conditions and raw material prices. The company’s historical sales performance reflects a dip from ₹197 Cr in March 2022 to ₹149 Cr in March 2023, highlighting the need for strategic initiatives to stabilize and grow revenue going forward.
Profitability and Efficiency Metrics
Sanginita Chemicals has faced significant challenges in profitability, as evidenced by its operating profit margin (OPM), which stood at -4.03% as of December 2025. The company reported net profits fluctuating between ₹0.29 Cr and a loss of ₹2.78 Cr over the recent quarters, indicating a lack of consistent profitability. The interest coverage ratio (ICR) was recorded at 2.03x, suggesting that the company can cover its interest expenses but is operating on a thin margin. The return on equity (ROE) was a mere 1.28%, reflecting the inefficiency in generating returns from shareholders’ equity. Furthermore, the return on capital employed (ROCE) at 4.19% underlines the challenges in effectively utilizing capital for profitable growth. These profitability metrics indicate the need for operational improvements, as the company’s performance is below typical sector norms, where companies often report higher margins and returns.
Balance Sheet Strength and Financial Ratios
The balance sheet of Sanginita Chemicals reveals a total borrowing of ₹26 Cr against reserves of ₹30 Cr, indicating a relatively balanced capital structure. The company’s debt-to-equity ratio stood at 0.46, suggesting moderate leverage, which is manageable given the industry context. The current ratio of 1.93x indicates a healthy liquidity position, allowing the company to meet its short-term obligations. However, the book value per share has declined from ₹23.62 in March 2024 to ₹21.68 in March 2025, reflecting a decrease in shareholder value. Additionally, the price-to-book value (P/BV) ratio of 0.41x suggests that the stock is trading below its book value, which could imply undervaluation or investor skepticism regarding future performance. Overall, while the balance sheet shows some strengths in liquidity and leverage, the declining book value raises concerns about the company’s ability to maintain shareholder confidence.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Sanginita Chemicals has seen a significant shift, with promoters holding 30% as of September 2025, down from over 62% in late 2022. This reduction in promoter holding may reflect a loss of confidence in the company’s future prospects, which is critical for investor sentiment. The public stake has increased to 70%, indicating a diversification of ownership but also a potential dilution of control. The number of shareholders has grown from 9,646 in December 2022 to 16,654 in September 2025, suggesting an increase in retail investor interest. However, the declining promoter stake and the company’s poor financial performance may lead to skepticism among institutional investors, as indicated by the absence of foreign or domestic institutional investors. This shift in ownership dynamics could influence the company’s strategic direction and operational focus moving forward.
Outlook, Risks, and Final Insight
The outlook for Sanginita Chemicals is contingent upon its ability to stabilize revenues and improve profitability. Key risks include the volatility in raw material prices and the potential for further declines in sales, which could exacerbate the already negative profit margins. Additionally, the substantial reduction in promoter holding may lead to governance concerns, impacting long-term strategic decisions. Conversely, the company’s strong liquidity position offers some buffer against immediate financial pressures, while an increased public shareholding could enhance market interest if operational improvements are realized. The company must focus on enhancing operational efficiencies and exploring new market opportunities to regain investor confidence and achieve sustainable growth. If successful, Sanginita Chemicals could leverage its low P/BV ratio as an attractive entry point for value investors, but failure to address its profitability challenges may result in continued underperformance in the competitive chemicals sector.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Gujchem Distillers India Ltd | 73.2 Cr. | 205 | 456/192 | 170 | 392 | 0.05 % | 0.21 % | 0.09 % | 1.00 |
| Elantas Beck India Ltd | 7,083 Cr. | 8,935 | 14,250/8,150 | 51.3 | 1,177 | 0.08 % | 23.0 % | 17.4 % | 10.0 |
| Crestchem Ltd | 30.1 Cr. | 100 | 329/93.4 | 14.9 | 26.9 | 1.00 % | 59.9 % | 44.1 % | 10.0 |
| Chemiesynth (Vapi) Ltd | 11.6 Cr. | 37.6 | 37.6/35.8 | 32.8 | 0.00 % | 3.10 % | 0.99 % | 10.0 | |
| ARCL Organics Ltd | 224 Cr. | 280 | 435/163 | 12.4 | 108 | 0.00 % | 20.4 % | 16.8 % | 10.0 |
| Industry Average | 4,547.08 Cr | 1,466.67 | 59.95 | 334.84 | 0.41% | 14.71% | 10.69% | 7.56 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 33.51 | 33.82 | 35.90 | 33.41 | 29.16 | 53.04 | 56.95 | 61.34 | 61.54 | 49.85 | 45.91 | 44.10 | 43.47 |
| Expenses | 32.40 | 33.24 | 34.69 | 31.98 | 27.94 | 52.94 | 55.67 | 60.08 | 60.38 | 48.87 | 45.11 | 43.77 | 45.22 |
| Operating Profit | 1.11 | 0.58 | 1.21 | 1.43 | 1.22 | 0.10 | 1.28 | 1.26 | 1.16 | 0.98 | 0.80 | 0.33 | -1.75 |
| OPM % | 3.31% | 1.71% | 3.37% | 4.28% | 4.18% | 0.19% | 2.25% | 2.05% | 1.88% | 1.97% | 1.74% | 0.75% | -4.03% |
| Other Income | 0.05 | 0.11 | 0.07 | 0.08 | 0.25 | 0.04 | 0.04 | 0.13 | 0.08 | 0.01 | 0.37 | 0.01 | 0.00 |
| Interest | 0.63 | 0.68 | 0.66 | 0.62 | 0.66 | 0.68 | 0.64 | 0.63 | 0.58 | 0.59 | 0.53 | 0.47 | 0.49 |
| Depreciation | 0.14 | 0.14 | 0.15 | 0.16 | 0.20 | 0.24 | 0.26 | 0.47 | 0.48 | 0.47 | 0.54 | 0.56 | 0.55 |
| Profit before tax | 0.39 | -0.13 | 0.47 | 0.73 | 0.61 | -0.78 | 0.42 | 0.29 | 0.18 | -0.07 | 0.10 | -0.69 | -2.79 |
| Tax % | 23.08% | -30.77% | 25.53% | 26.03% | 26.23% | -24.36% | 26.19% | 24.14% | 27.78% | -14.29% | -10.00% | -1.45% | -0.36% |
| Net Profit | 0.29 | -0.10 | 0.35 | 0.54 | 0.46 | -0.58 | 0.31 | 0.22 | 0.14 | -0.05 | 0.11 | -0.68 | -2.78 |
| EPS in Rs | 0.11 | -0.04 | 0.14 | 0.21 | 0.18 | -0.22 | 0.12 | 0.08 | 0.05 | -0.02 | 0.04 | -0.26 | -1.07 |
Last Updated: January 10, 2026, 6:47 pm
Below is a detailed analysis of the quarterly data for Sanginita Chemicals Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 43.47 Cr.. The value appears to be declining and may need further review. It has decreased from 44.10 Cr. (Sep 2025) to 43.47 Cr., marking a decrease of 0.63 Cr..
- For Expenses, as of Dec 2025, the value is 45.22 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 43.77 Cr. (Sep 2025) to 45.22 Cr., marking an increase of 1.45 Cr..
- For Operating Profit, as of Dec 2025, the value is -1.75 Cr.. The value appears to be declining and may need further review. It has decreased from 0.33 Cr. (Sep 2025) to -1.75 Cr., marking a decrease of 2.08 Cr..
- For OPM %, as of Dec 2025, the value is -4.03%. The value appears to be declining and may need further review. It has decreased from 0.75% (Sep 2025) to -4.03%, marking a decrease of 4.78%.
- For Other Income, as of Dec 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.01 Cr. (Sep 2025) to 0.00 Cr., marking a decrease of 0.01 Cr..
- For Interest, as of Dec 2025, the value is 0.49 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.47 Cr. (Sep 2025) to 0.49 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Dec 2025, the value is 0.55 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.56 Cr. (Sep 2025) to 0.55 Cr., marking a decrease of 0.01 Cr..
- For Profit before tax, as of Dec 2025, the value is -2.79 Cr.. The value appears to be declining and may need further review. It has decreased from -0.69 Cr. (Sep 2025) to -2.79 Cr., marking a decrease of 2.10 Cr..
- For Tax %, as of Dec 2025, the value is -0.36%. The value appears to be increasing, which may not be favorable. It has increased from -1.45% (Sep 2025) to -0.36%, marking an increase of 1.09%.
- For Net Profit, as of Dec 2025, the value is -2.78 Cr.. The value appears to be declining and may need further review. It has decreased from -0.68 Cr. (Sep 2025) to -2.78 Cr., marking a decrease of 2.10 Cr..
- For EPS in Rs, as of Dec 2025, the value is -1.07. The value appears to be declining and may need further review. It has decreased from -0.26 (Sep 2025) to -1.07, marking a decrease of 0.81.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:30 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 119 | 129 | 151 | 155 | 197 | 188 | 160 | 164 | 197 | 149 | 151 | 230 | 201 |
| Expenses | 114 | 124 | 147 | 150 | 189 | 178 | 151 | 160 | 195 | 145 | 147 | 225 | 198 |
| Operating Profit | 5 | 4 | 5 | 5 | 8 | 9 | 8 | 4 | 3 | 3 | 4 | 5 | 3 |
| OPM % | 4% | 3% | 3% | 3% | 4% | 5% | 5% | 2% | 1% | 2% | 3% | 2% | 2% |
| Other Income | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Interest | 3 | 3 | 3 | 3 | 2 | 3 | 3 | 3 | 2 | 2 | 3 | 2 | 2 |
| Depreciation | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 1 | 1 | 2 | 2 | 5 | 5 | 4 | 1 | 0 | 1 | 1 | 1 | -0 |
| Tax % | 35% | 32% | 32% | 34% | 33% | 28% | 25% | 25% | 24% | 23% | 27% | 25% | |
| Net Profit | 1 | 1 | 1 | 1 | 3 | 4 | 3 | 1 | 0 | 0 | 1 | 1 | -0 |
| EPS in Rs | 0.68 | 0.81 | 0.87 | 0.43 | 1.33 | 1.52 | 1.30 | 0.29 | 0.14 | 0.16 | 0.30 | 0.24 | -0.19 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | 200.00% | 33.33% | -25.00% | -66.67% | -100.00% | 0.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | 0.00% | 200.00% | -166.67% | -58.33% | -41.67% | -33.33% | 100.00% |
Sanginita Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 9 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 8% |
| 3 Years: | 5% |
| TTM: | 27% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -29% |
| 3 Years: | 21% |
| TTM: | -42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -31% |
| 3 Years: | -22% |
| 1 Year: | -41% |
| Return on Equity | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 1:25 pm
Balance Sheet
Last Updated: December 10, 2025, 3:21 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 26 | 26 |
| Reserves | 6 | 7 | 8 | 11 | 14 | 18 | 21 | 22 | 22 | 23 | 24 | 30 | 30 |
| Borrowings | 23 | 23 | 25 | 26 | 26 | 29 | 35 | 29 | 35 | 29 | 33 | 26 | 26 |
| Other Liabilities | 7 | 12 | 2 | 7 | 3 | 7 | 5 | 2 | 5 | 11 | 12 | 20 | 20 |
| Total Liabilities | 44 | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 80 | 86 | 102 | 102 |
| Fixed Assets | 5 | 4 | 4 | 3 | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 15 | 14 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 40 | 46 | 40 | 57 | 57 | 67 | 74 | 66 | 75 | 75 | 78 | 87 | 88 |
| Total Assets | 44 | 50 | 44 | 60 | 61 | 72 | 78 | 70 | 79 | 80 | 86 | 102 | 102 |
Below is a detailed analysis of the balance sheet data for Sanginita Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Reserves, as of Sep 2025, the value is 30.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 30.00 Cr..
- For Borrowings, as of Sep 2025, the value is 26.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 26.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 102.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 102.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 14.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 14.00 Cr., marking a decrease of 1.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 88.00 Cr.. The value appears strong and on an upward trend. It has increased from 87.00 Cr. (Mar 2025) to 88.00 Cr., marking an increase of 1.00 Cr..
- For Total Assets, as of Sep 2025, the value is 102.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 102.00 Cr..
Notably, the Reserves (30.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -18.00 | -19.00 | -20.00 | -21.00 | -18.00 | -20.00 | -27.00 | -25.00 | -32.00 | -26.00 | -29.00 | -21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 64 | 86 | 64 | 96 | 66 | 62 | 89 | 65 | 46 | 63 | 64 | 58 |
| Inventory Days | 48 | 41 | 30 | 29 | 29 | 39 | 50 | 51 | 46 | 70 | 76 | 49 |
| Days Payable | 14 | 32 | 2 | 15 | 3 | 8 | 7 | 2 | 8 | 25 | 27 | 22 |
| Cash Conversion Cycle | 98 | 95 | 93 | 109 | 92 | 93 | 132 | 114 | 84 | 107 | 112 | 85 |
| Working Capital Days | 99 | 34 | 33 | 58 | 52 | 60 | 78 | 78 | 72 | 81 | 86 | 67 |
| ROCE % | 12% | 11% | 11% | 10% | 14% | 14% | 11% | 5% | 4% | 4% | 5% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.24 | 0.45 | 0.24 | 0.20 | 0.44 |
| Diluted EPS (Rs.) | 0.24 | 0.45 | 0.24 | 0.20 | 0.44 |
| Cash EPS (Rs.) | 0.88 | 0.87 | 0.56 | 0.53 | 0.82 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 21.68 | 23.62 | 23.24 | 23.00 | 22.80 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 21.68 | 23.62 | 23.24 | 23.00 | 22.80 |
| Revenue From Operations / Share (Rs.) | 88.67 | 87.74 | 86.03 | 114.70 | 95.36 |
| PBDIT / Share (Rs.) | 1.91 | 2.55 | 2.09 | 1.80 | 2.46 |
| PBIT / Share (Rs.) | 1.26 | 2.12 | 1.77 | 1.47 | 2.08 |
| PBT / Share (Rs.) | 0.31 | 0.60 | 0.31 | 0.26 | 0.59 |
| Net Profit / Share (Rs.) | 0.23 | 0.44 | 0.24 | 0.20 | 0.44 |
| PBDIT Margin (%) | 2.15 | 2.91 | 2.42 | 1.56 | 2.57 |
| PBIT Margin (%) | 1.42 | 2.41 | 2.05 | 1.27 | 2.17 |
| PBT Margin (%) | 0.36 | 0.68 | 0.37 | 0.23 | 0.62 |
| Net Profit Margin (%) | 0.26 | 0.50 | 0.28 | 0.17 | 0.46 |
| Return on Networth / Equity (%) | 1.10 | 1.88 | 1.03 | 0.87 | 1.93 |
| Return on Capital Employeed (%) | 5.69 | 8.39 | 7.22 | 5.84 | 9.05 |
| Return On Assets (%) | 0.60 | 0.89 | 0.52 | 0.43 | 1.08 |
| Long Term Debt / Equity (X) | 0.01 | 0.06 | 0.05 | 0.08 | 0.00 |
| Total Debt / Equity (X) | 0.46 | 0.80 | 0.71 | 0.86 | 0.73 |
| Asset Turnover Ratio (%) | 2.44 | 1.83 | 1.87 | 2.65 | 2.22 |
| Current Ratio (X) | 1.93 | 1.85 | 1.89 | 2.09 | 2.16 |
| Quick Ratio (X) | 1.27 | 1.14 | 1.16 | 1.42 | 1.44 |
| Inventory Turnover Ratio (X) | 7.70 | 3.72 | 4.74 | 7.82 | 6.82 |
| Interest Coverage Ratio (X) | 2.03 | 1.68 | 1.44 | 1.51 | 1.66 |
| Interest Coverage Ratio (Post Tax) (X) | 1.25 | 1.29 | 1.17 | 1.17 | 1.30 |
| Enterprise Value (Cr.) | 49.65 | 66.52 | 61.28 | 70.59 | 62.18 |
| EV / Net Operating Revenue (X) | 0.21 | 0.43 | 0.41 | 0.35 | 0.37 |
| EV / EBITDA (X) | 10.05 | 15.09 | 17.00 | 22.70 | 14.64 |
| MarketCap / Net Operating Revenue (X) | 0.10 | 0.22 | 0.22 | 0.18 | 0.20 |
| Price / BV (X) | 0.41 | 0.82 | 0.81 | 0.90 | 0.84 |
| Price / Net Operating Revenue (X) | 0.10 | 0.22 | 0.22 | 0.18 | 0.20 |
| EarningsYield | 0.02 | 0.02 | 0.01 | 0.01 | 0.02 |
After reviewing the key financial ratios for Sanginita Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 0.45 (Mar 24) to 0.24, marking a decrease of 0.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.24. This value is below the healthy minimum of 5. It has decreased from 0.45 (Mar 24) to 0.24, marking a decrease of 0.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 3. It has increased from 0.87 (Mar 24) to 0.88, marking an increase of 0.01.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.68. It has decreased from 23.62 (Mar 24) to 21.68, marking a decrease of 1.94.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 21.68. It has decreased from 23.62 (Mar 24) to 21.68, marking a decrease of 1.94.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 88.67. It has increased from 87.74 (Mar 24) to 88.67, marking an increase of 0.93.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 1.91. This value is below the healthy minimum of 2. It has decreased from 2.55 (Mar 24) to 1.91, marking a decrease of 0.64.
- For PBIT / Share (Rs.), as of Mar 25, the value is 1.26. This value is within the healthy range. It has decreased from 2.12 (Mar 24) to 1.26, marking a decrease of 0.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.31. This value is within the healthy range. It has decreased from 0.60 (Mar 24) to 0.31, marking a decrease of 0.29.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 2. It has decreased from 0.44 (Mar 24) to 0.23, marking a decrease of 0.21.
- For PBDIT Margin (%), as of Mar 25, the value is 2.15. This value is below the healthy minimum of 10. It has decreased from 2.91 (Mar 24) to 2.15, marking a decrease of 0.76.
- For PBIT Margin (%), as of Mar 25, the value is 1.42. This value is below the healthy minimum of 10. It has decreased from 2.41 (Mar 24) to 1.42, marking a decrease of 0.99.
- For PBT Margin (%), as of Mar 25, the value is 0.36. This value is below the healthy minimum of 10. It has decreased from 0.68 (Mar 24) to 0.36, marking a decrease of 0.32.
- For Net Profit Margin (%), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 5. It has decreased from 0.50 (Mar 24) to 0.26, marking a decrease of 0.24.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.10. This value is below the healthy minimum of 15. It has decreased from 1.88 (Mar 24) to 1.10, marking a decrease of 0.78.
- For Return on Capital Employeed (%), as of Mar 25, the value is 5.69. This value is below the healthy minimum of 10. It has decreased from 8.39 (Mar 24) to 5.69, marking a decrease of 2.70.
- For Return On Assets (%), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 5. It has decreased from 0.89 (Mar 24) to 0.60, marking a decrease of 0.29.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.01, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has decreased from 0.80 (Mar 24) to 0.46, marking a decrease of 0.34.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 2.44. It has increased from 1.83 (Mar 24) to 2.44, marking an increase of 0.61.
- For Current Ratio (X), as of Mar 25, the value is 1.93. This value is within the healthy range. It has increased from 1.85 (Mar 24) to 1.93, marking an increase of 0.08.
- For Quick Ratio (X), as of Mar 25, the value is 1.27. This value is within the healthy range. It has increased from 1.14 (Mar 24) to 1.27, marking an increase of 0.13.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.70. This value is within the healthy range. It has increased from 3.72 (Mar 24) to 7.70, marking an increase of 3.98.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 2.03. This value is below the healthy minimum of 3. It has increased from 1.68 (Mar 24) to 2.03, marking an increase of 0.35.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.25. This value is below the healthy minimum of 3. It has decreased from 1.29 (Mar 24) to 1.25, marking a decrease of 0.04.
- For Enterprise Value (Cr.), as of Mar 25, the value is 49.65. It has decreased from 66.52 (Mar 24) to 49.65, marking a decrease of 16.87.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.21. This value is below the healthy minimum of 1. It has decreased from 0.43 (Mar 24) to 0.21, marking a decrease of 0.22.
- For EV / EBITDA (X), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 15.09 (Mar 24) to 10.05, marking a decrease of 5.04.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.10, marking a decrease of 0.12.
- For Price / BV (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.82 (Mar 24) to 0.41, marking a decrease of 0.41.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.22 (Mar 24) to 0.10, marking a decrease of 0.12.
- For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Sanginita Chemicals Ltd:
- Net Profit Margin: 0.26%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 5.69% (Industry Average ROCE: 14.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.1% (Industry Average ROE: 10.69%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.25
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 59.95)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.46
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.26%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Organic - Others | No.301, 3rd Floor, Gandhinagar Gujarat 382011 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dineshsinh B Chavada | Chairperson & Managing Director |
| Mr. Vijaysinh D Chavda | Whole Time Director |
| Mr. Faiyazkhan Y Pathan | Independent Director |
| Mr. Jagdishkumar V Thakor | Independent Director |
| Mr. Pramodsinh D Dabhi | Independent Director |
| Mrs. Hansaben D Chavda | Director |
FAQ
What is the intrinsic value of Sanginita Chemicals Ltd?
Sanginita Chemicals Ltd's intrinsic value (as of 16 January 2026) is ₹3.35 which is 70.35% lower the current market price of ₹11.30, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹29.2 Cr. market cap, FY2025-2026 high/low of ₹14.8/8.46, reserves of ₹30 Cr, and liabilities of ₹102 Cr.
What is the Market Cap of Sanginita Chemicals Ltd?
The Market Cap of Sanginita Chemicals Ltd is 29.2 Cr..
What is the current Stock Price of Sanginita Chemicals Ltd as on 16 January 2026?
The current stock price of Sanginita Chemicals Ltd as on 16 January 2026 is ₹11.3.
What is the High / Low of Sanginita Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Sanginita Chemicals Ltd stocks is ₹14.8/8.46.
What is the Stock P/E of Sanginita Chemicals Ltd?
The Stock P/E of Sanginita Chemicals Ltd is .
What is the Book Value of Sanginita Chemicals Ltd?
The Book Value of Sanginita Chemicals Ltd is 21.4.
What is the Dividend Yield of Sanginita Chemicals Ltd?
The Dividend Yield of Sanginita Chemicals Ltd is 0.00 %.
What is the ROCE of Sanginita Chemicals Ltd?
The ROCE of Sanginita Chemicals Ltd is 4.19 %.
What is the ROE of Sanginita Chemicals Ltd?
The ROE of Sanginita Chemicals Ltd is 1.28 %.
What is the Face Value of Sanginita Chemicals Ltd?
The Face Value of Sanginita Chemicals Ltd is 10.0.